| Heading: |
Prostate Cancer: Screening |
| Question ID: |
1745483 |
| UIN: |
16839 |
| House: |
Commons |
| Date tabled: |
2024-11-28 |
| Asking Member ID: |
5329 |
| Asking Member display name: |
John Milne
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
John Milne
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, with reference to Prostate Cancer UK's research entitled Optimising the use of the prostate-?specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: rep |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2024-12-05 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
1506 |
| Answering Member display name: |
Andrew Gwynne
|
| Answering Member handle: |
GwynneMP
|
| Answering Member Twitter reference: |
@GwynneMP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The UK National Screening Committee is aware of the Prostate Cancer UK report, and this will be considered as part of its evidence review process, with further information available at the following link:https://www.gov.uk/government/publications/uk-nsc-e... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |